NEUROCRINE BIOSCIENCES INC

Ticker: NBIX CUSIP: 64125C109 Class: EQTY

PRIMECAP MANAGEMENT CO/CA/'s Holding History (CIK: 0000763212)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 507,740 Value ($000) $72,013 Avg Close $144.87 Range $133.61 - $160.18
Q3 2025
Shares 512,260 Value ($000) $71,911 Avg Close $135.50 Range $123.67 - $148.00
Q2 2025
Shares 524,040 Value ($000) $65,867 Avg Close $114.68 Range $84.23 - $130.46
Q1 2025
Shares 382,440 Value ($000) $42,298 Avg Close $126.68 Range $105.18 - $154.61
Q4 2024
Shares 393,710 Value ($000) $53,741 Avg Close $123.68 Range $110.95 - $140.00
Q3 2024
Shares 404,000 Value ($000) $46,549 Avg Close $137.09 Range $114.08 - $157.98
Q2 2024
Shares 409,290 Value ($000) $56,347 Avg Close $137.14 Range $129.33 - $145.78
Q1 2024
Shares 399,380 Value ($000) $55,082 Avg Close $136.57 Range $128.00 - $148.37
Q4 2023
Shares 398,323 Value ($000) $52,483 Avg Close $115.11 Range $103.63 - $133.64
Q3 2023
Shares 391,585 Value ($000) $44,053 Avg Close $105.30 Range $93.28 - $119.29
Q2 2023
Shares 393,360 Value ($000) $37,094 Avg Close $97.71 Range $89.04 - $107.98
Q1 2023
Shares 371,740 Value ($000) $37,628 Avg Close $104.06 Range $92.89 - $125.02
Q4 2022
Shares 5,100 Value ($000) $609 Avg Close $117.13 Range $105.14 - $129.29